Search results

...y using PCV for tumors recurrent after radiation (and for some after prior chemotherapy); 13% in a study with PCV after Temodar failure |usefulness_explanation=While BCNU has been a standard chemotherapy treatment for GBM for decades, its efficacy, especially as a single agent i ...

...ratory and Phase 1/2 trials for recurrent glioma in combination with other agents |usefulness_explanation=Carboplatin, especially in combination with agents like Talazoparib, represents a promising line of investigation for recurren ...

|OS_with=Not specified; however, survival six months after recurrence was used as a primary measure in comparative studies with Avastin ...pecially when administered every two weeks for five consecutive treatments at a dose of 80 mg/sq.-meter followed by maintenance therapy every four weeks. ...

|used_for=Recurrent Glioblastoma Multiforme (GBM) and other malignant gliomas |clinical_trial_phase=Phase I/II trials in combination with other therapies ...

...leveraging a unique mechanism of action that differs from other alkylating agents. Its effectiveness in patients with specific genetic markers, such as an un |treatment_category=Other chemotherapy agents at recurrence ...

Since my own diagnosis of glioblastoma (GBM) in 1995 at age 50, I have spent treatments that are described. References are presented at the end for those who would ...